Company intelligence / Profile preview
Natural Pharmacia International
- Ownership
- Private
- Employees
- ~8
- Development stage
- Other
Overview
NPI has a robust pipeline of Traditional Chinese Medicine-based botanical drugs, some in clinical trials. Notably, "Alkontrol herbal" is being developed for alcohol dependence and has advanced through preclinical validation with ongoing efforts to scale up GMP production and conduct proof-of-concept clinical trials. The company also markets dietary supplements under the DR.LEE+TCM brand while pursuing FDA approval for select botanical drugs[1][2].
- Therapeutic areas
- PsychiatryRheumatologyOther
- Modalities
- Botanical drugHerbal supplementSmall molecule (bioactive single-molecules from herbs)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Natural Pharmacia International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Natural Pharmacia International.